The global primary cells market size is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7% during the forecast period. Primary cells are widely used in applications such as 3D cell culture, virology, cancer research, stem cell therapy, and tissue replacement. Researchers are increasingly using products for 3D cell culture to analyze cell biology and biochemistry, drug effects, cell signaling, and cell and pathogen interactions.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

Growth in this market is largely driven by the rising prevalence of cancer, increasing focus on the development of novel cancer therapies, and rising adoption of primary cells over cell lines.

Market Segmentation

Based on type, the primary cells market is segmented into hematopoietic cells, dermatocytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and other primary cells. the hepatocytes segment accounted for the highest growth rate.

Based on end-users, the primary cells market is segmented into life science research companies and research institutes. the life science research companies segment for the largest share in the primary cells market.

Regional Analysis

North America accounted for the largest share in the primary cells market. The growth in the North American primary cells market can be attributed to increasing funding for cancer research, growing life science research sector, expansion of the healthcare sector, and the high adoption of stem cell therapy & cell immunotherapies for the treatment of cancer and chronic diseases.

Key Market Players

The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US), ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US), Axol Bioscience Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US), BioIVT (US), ScienCell Research Laboratories, Inc. (US), PPA Research Group, Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix Sàrl (Switzerland), ReachBio LLC (US), AcceGen (US), Sekisui XenoTech, LLC (US), and Biopredic International (France).

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32854960

Thermo Fisher Scientific accounted for the largest share of the primary cells market in 2019. The company maintains its leading position in the primary cells market due to its well-established product portfolio. The company adopted partnerships and expansions as key strategies to strengthen its position as well as expand its product portfolio.

Frequently Asked Questions (FAQ):
• What are the recent trends affecting the primary cells market?
• What are the different types of primary cells used?
• Who are the key players in the primary cells market?
• Who are the key end-users of the primary cells market?
• Which region is lucrative for the primary cells market?